Genmab
Overview
Genmab is a biotechnology company specializing in the creation and development of differentiated antibody therapeutics for the treatment of cancer and other serious diseases. Founded in 1999, Genmab is headquartered in Copenhagen, Denmark, with additional offices in Utrecht, Netherlands, and Princeton, New Jersey, United States.
History
Genmab was established in 1999 by a team of scientists and entrepreneurs with the goal of developing innovative antibody-based therapies. The company quickly gained recognition for its proprietary technology platforms and its ability to generate high-quality therapeutic antibodies.
Technology Platforms
Genmab utilizes several proprietary technology platforms to develop its antibody therapeutics. These include:
- DuoBody® Platform: A technology for generating bispecific antibodies that can bind to two different targets simultaneously.
- HexaBody® Platform: A technology designed to enhance the potency of antibodies by inducing hexamer formation.
- HexElect® Platform: A platform that combines the HexaBody and DuoBody technologies to create potent bispecific antibodies.
Key Products
Genmab has developed several key products that have been approved for clinical use or are in various stages of clinical development. Some of these include:
- Darzalex® (daratumumab): An antibody used in the treatment of multiple myeloma.
- Kesimpta® (ofatumumab): An antibody used for the treatment of relapsing forms of multiple sclerosis.
Research and Development
Genmab is committed to advancing its pipeline of antibody therapeutics through rigorous research and development. The company collaborates with various academic institutions and pharmaceutical companies to enhance its R&D capabilities.
Collaborations and Partnerships
Genmab has established strategic partnerships with several leading pharmaceutical companies, including Johnson & Johnson and Novartis, to co-develop and commercialize its antibody products.
Corporate Social Responsibility
Genmab is dedicated to conducting its business in a socially responsible manner. The company focuses on sustainability, ethical business practices, and contributing to the communities in which it operates.
See Also
Related Pages
Transform your life with W8MD's budget GLP-1 injections from $125.
W8MD offers a medical weight loss program to lose weight in Philadelphia. Our physician-supervised medical weight loss provides:
- Most insurances accepted or discounted self-pay rates. We will obtain insurance prior authorizations if needed.
- Generic GLP1 weight loss injections from $125 for the starting dose.
- Also offer prescription weight loss medications including Phentermine, Qsymia, Diethylpropion, Contrave etc.
NYC weight loss doctor appointments
Start your NYC weight loss journey today at our NYC medical weight loss and Philadelphia medical weight loss clinics.
- Call 718-946-5500 to lose weight in NYC or for medical weight loss in Philadelphia 215-676-2334.
- Tags:NYC medical weight loss, Philadelphia lose weight Zepbound NYC, Budget GLP1 weight loss injections, Wegovy Philadelphia, Wegovy NYC, Philadelphia medical weight loss, Brookly weight loss and Wegovy NYC
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Contributors: Prab R. Tumpati, MD
